DiaPep277®

DRUG2 trials

Sponsors

Hadassah Medical Organization, Andromeda Biotech Ltd.

Conditions

Type 1 DiabetesType One Diabetes

Phase 1

The Safety and Efficacy of Administrating DiaPep277® Vaccination in Type 1 Diabetes Patients.

WithdrawnNCT01881958

Hadassah Medical OrganizationType One Diabetes

Start: 2015-01-31End: 2017-01-31Updated: 2018-03-06

Phase 3

Open-Label Extension Study to Evaluate Long Term Safety and Treatment Effect of DiaPep277®

TerminatedNCT01898286

Andromeda Biotech Ltd.Type 1 Diabetes

Start: 2013-10-31End: 2014-12-31Updated: 2016-05-26